Suchergebnisse - (Subject:"ritonavir")

PubPharm (1.001)

1

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

2

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication

enthalten in: Antiviral research | 2024

von Moon, C. | Porges, E. | Roberts, A. | +1

3

Review : The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Meyerowitz, E. | Li, Y.

4

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

5

COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Henderson, H. | Wohl, D. | Fischer, W. | +8

6

The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance

enthalten in: Antiviral research | 2024

von Schreiber, A. | Rodner, F. | Oberberg, N. | +5

7

Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era : a systematic review

enthalten in: Expert opinion on drug metabolism & toxicology | 2024

von Conti, V. | Bertini, N. | Ricciardi, R. | +8

8

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system

enthalten in: Scientific reports | 2024

von Malden, D. | McLaughlin, J. | Hong, V. | +8

9

Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma : A case series

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Huang, L. | Tong, X. | Cui, J. | +8

10

Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease

enthalten in: Virology journal | 2024

von Colaneri, M. | Scaglione, G. | Fassio, F. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[101]